Nutritional phenolics and cardiovascular disease

Phytochemical Functional Foods

Volumn , Issue , 2003, Pages 5-17

  Virgili, F ^a   Scaccini, C ^a   Packer, L ^b   Rimbach, G ^c  

^a Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902892434     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-85573-672-6.50006-X     Document Type: Chapter

References (49)

1. M G L HERTOG, E J M FESRENS, P C K HOLLMAN, M B KATAN and D KROMHOUT (1993) ‘Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study’. The Lancet 342 1007-1011.
2. M J STAMPFER, C H HENNEKENS, J E MANSON, G A COLDITZ, B ROSNER and W C WILLET (1993) ‘Vitamin E consumption and the risk of coronary disease in women’. New England Journal of Medicine 328 1444-1449.
3. M NAVAB, A M FOGELMAN, J A BERLINER, M C TERRITO, L L DEMER, J S FRANK, A D WATSON, P A EDWARDS and A J LUSIS (1995) ‘Pathogenesis of arteriosclerosis’. American Journal of Cardiology 76 18-23.
4. N A NELKEN, S R COUGHLIN, D GORDON and J N WILCOX (1991) ‘Monocyte chemoattractant protein-1 in human atheromatous plaques’. Journal of Clinical Investigation 88 1121-1127.
5. J M WANG, W P SHEN and S B SU (1998) ‘Chemokines and their role in cardiovascular diseases’. Trends in Cardiovascular Medicine 8 169-174.
6. R ROSS (1993) ‘The pathogenesis of atheriosclerosis: a perspective for the 1990 s’. Nature 362 801-809.
7. J A BERLINER and J W HEINECKE (1996) ‘The role of oxidized lipoproteins in atherosclerosis’. Free Radical Biology and Medicine 20 707-727.
8. S F THAI, J G LEWIS, R B WILLIAMS, S P JOHNSON and D O ADAMS (1995) ‘Effects of oxidized LDL on mononuclear phagocytes: inhibition of induction of four inflammatory cytokine gene RNAs, release of NO, and cytolysis of tumor cells’. Journal of Leukocyte Biology 57 427-433.
9. T B RAJAVASHISTH, H YAMADA and N K MISHRA (1995) ‘Transcriptional activation of macrophage stimulating factor gene by minimally modified LDL’. Arteriosclerosis, Thrombosis and Vascular Biology 15 1591-1598.
10. U P STEINBRECHER, H ZHANG and M L LOUGHEED (1990) ‘Role of oxidatively modified LDL in atherosclerosis’. Free Radical Biology and Medicine 9 155-168.
11. F PARHAMI, Z T FANG, A M FOGELMAN, A ANDALIBI, M C TERRITO and J A BERLINER (1993) ‘Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate’. Journal of Clinical Investigation 92 471-478.
12. T B RAJAVASHISTH, H YAMADA and N K MISHRA (1995) ‘Transcriptional activation of macrophage stimulating factor gene by minimally modified LDL’. Arteriosclerosis, Thrombosis and Vascular Biology 15 1591-1598.
13. J FRUEBIS, V GONZALEZ, M SILVESTRE and W PALINSKI (1997) ‘Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis’. Arteriosclerosis, Thrombosis and Vascular Biology 17 1289-1302.
14. M KLOUCHE, S GOTTSCHLING, V GERL, W HELL, M HUSMANN, B DORWEILER, M MESSNER and S BHAKDI (1998) ‘Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages’. Arteriosclerosis, Thrombosis and Vascular Biology 18 1376-1385.
15. M KAPLAN and M AVIRAM (1999) ‘Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase’. Clinical Chemistry Laboratory Medicine 37 777-787.
16. H DREXLER and B HORNIG (1999) ‘Endothelial dysfunction in human disease’. Journal of Molecular and Cellular Cardiology 31 51-60.
17. G H GIBBONS and V J DZAU (1996) ‘Molecular therapies for vascular disease’. Science 272 689-693.
18. M S BROWN and J L GOLDSTEIN (1990) ‘Scavenging for receptors’. Nature 343 508-509.
19. H ESTERBAUER, J GEBIKI, H PUHL and G JURGENS (1992) ‘The role of lipid peroxidation and antioxidants in oxidative modification of LDL’. Free Radical Biology and Medicine 13 341-390.
20. W BORS, W HELLER, C MICHEL and M SARAN (1990) ‘Flavonoids as antioxidants: determination of radical-scavenging efficiency’. Methods in Enzymology 186 343-355.
21. C A RICE-EVANS, N J MILLER and G PANANGA (1997) ‘Structure-antioxidant activity relationship of flavonoids and phenolic acids’. L Packer, C A Rice-Evans,(Eds) Flavonoids in Health and Disease New York: Marcel Dekker 199-209.
22. J A BERLINER, M NAVAB, A M FOGELMAN, J S FRANK, L L DEMER, P A EDWARDS, A D WATSON and A J LUSIS (1995) ‘Arteriosclerosis: basic mechanisms - oxidation, inflammation and genetics’. Circulation 91 2488-2496.
23. P A BAEUERLE and T HENKEL (1994) ‘Function and activation of NFkB in the immune system’. Annual Review in Immunology 12 141-179.
24. K BRAND, S PAGE, A K WALLI, D NEUMAIER and P A BAEUERLE (1997) ‘Role of nuclear factor kB in atherogenesis’. Experimental Physiology 82 297-304.
25. Y J SUZUKI, H J FORMAN and A SEVANIAN (1997) ‘Oxidants as stimulators of signal transduction’. Free Radical Biology and Medicine 22 269-285.
26. E J MIDDLETON and C KANDASHWAMI (1992) ‘Effects of flavonoids on immune and inflammatory cell function.’. Biochemical Pharmacology 43 1167-1179.
27. P C FERRIOLA, V CODY and E MIDDLETON (1989) ‘Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure activity relationship’. Biochemical Pharmacology 38 1617-1624.
28. M CUSHMAN, D NAGARATHMAN, D L BURG and R L GEAHLEN (1991) ‘Synthesis and protein-tyrosine kinase inhibitory activity of flavonoids analogues’. Journal of Medicinal Chemistry 34 798-806.
29. M HAGIWARA, S INOUE, T TANAKA, K NUNOKI, M ITO and H HIDAKA (1988) ‘Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases’. Biochemical Pharmacology 37 2987-2992.
30. G AGULLO, L GAMET-PAYRASTRE, S MANENTI, C VIALA, C REMESY, H CHAP and B PAYRASTRE (1997) ‘Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition’. Biochemical Pharmacology 53 1649-1657.
31. J WOLLE, R R HILL, E FERGUSON, L J DEVALL, B K TRIVEDI, R S NEWTON and U SAXENA (1996) ‘Selective inhibition of tumor necrosis factor-induced vascular cell adhesion molecule-1 gene expression by a novel flavonoid. Lack of effect on trascriptional factor NFkB’. Arteriosclerosis, Thrombosis and Vascular Biology 16 1501-1508.
32. M NARDINI, C SCACCINI, L PACKER and F VIRGILI (2000) ‘In vivo inhibition of the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin rich pine bark (Pinus maritima) extract’. Biochimica Biophysica Acta 1474 219-225.
33. G HU, C HAN and J CHEN (1995) ‘Inhibition of oncogene expression by green tea and (-)-epigallocatechin gallate in mice’. Nutrition and Cancer 24 203-209.
34. Y T HUANG, M L KUO, J Y LIU, S Y HUANG and J K LIN (1996) ‘Inhibition of protein kinase C and proto-oncogene expression in NIH 3T3 cells by apigenin’. European Journal of Cancer 32A 146-151.
35. R YU, J J JIAO, J L DUH, K GUDEHITHLU, T H TAN and A N KONG (1997) ‘Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant responsive elements-mediated phase II enzyme gene expression’. Carcinogenesis 18 451-456.
36. J K LIN, Y C CHEN, Y T HUANG and S Y LIN-SHIAU (1997) ‘Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin’. Journal Cell Biochemistry Suppl 28-9 39-48.
37. X ZI, H MUKHTAR and R AGARVAL (1997) ‘Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: inhibition of mRNA expression of an endogenous tumor promoter TNF alpha’. Biochemical Biophysical Research Communications 239 334-339.
38. K BRAND, S PAGE, G ROGLER, A BARTSCH, R BRANDL, R KNUECHEL, M PAGE, C KALTSCHMIDT, P A BAEUERLE and D NEUMEIER (1996) ‘Activated transcription factor NF-kB is present in the atherioscleotic lesion’. Journal Clinical Investigation 97 1715-1722.
39. M E GERRITSEN, W W CARLEY, G E RANGES, C P SHEN, S A PHAN, G F LIGON and C A PERRY (1995) ‘Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression’. American Journal Patholology 147 278-292.
40. I M ADCOCK, C R BROWN, O KWON and P J BARNES (1994) ‘Oxidative stress induces NFkB DNA binding and inducible NOS mRNA in human epithelial cells’. Biochemical Biophysical Research Communications 199 1518-1524.
41. Y J SUZUKI, B B AGGARWAL and L PACKER (1992) ‘alpha-Lipoic acid is a potent inhibitor of NF-kB activation in human T cells’. Biochemical Biophysical Research Communications 189 1709-1715.
42. Y J SUZUKI and L PACKER (1993) ‘Inhibition of NF-KB activation by vitamin E derivatives’. Biochemical Biophysical Research Communications 193 277-283.
43. S ROY, C K SEN, H KOBUCHI and L PACKER (1998) ‘Antioxidant regulation of phorbol ester-induced adhesion of human Jurkat T-cells to endothelial cells’. Free Radical Biology and Medicine 25 229-241.
44. F VIRGILI, D KIM and L PACKER (1998) ‘Procyanidins extracted from pine bark protect α-tocopherol in ECV 304 endothelial cells challenged by activated RAW 264.7 macrophages: role of nitric oxide and peroxynitrite’. FEBS Letters 431 315-318.
45. G RIMBACH, F VIRGILI, Y C PARK and L PACKER (1999) ‘Effect of procyanidins from Pinus maritima on glutathione levels in endothelial cells challenged by 3-morpholinosyndonimine or activated macrophages’. Redox Report 4 171-177.
46. Z WEI, Q PENG and B H S LAU (1997) ‘Pycnogenol enhances endothelial cell antioxidant defences’. Redox Report 3 147-155.
47. G N RAO and B C BERK (1992) ‘Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression’. Circulation Research 70 593-599.
48. A D TASINATO, D BOISCOBOINIK, G M BARTOLI, P MARONI and A AZZI (1995) ‘d-a-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties’. Proceedings National Academy Sciences USA 92 12190-12194.
49. J-C TSAI, M JAIN, C-M HSIEH, W-S LEE, M YOSHIZUMI, C PATTERSON, M A PERRELLA, C COOKE, H WANG, E HABER, R SCHLEGEL and M E LEE (1996) ‘Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells’. Journal Biological Chemistry 271 3667-3670.